US$ 21.77
dihexa human clinical trials safety Dosage Protocol: Doses, Evidence & dihexa human trials status 2026
Description
Anticonvulsant Activity In rats with metaphit-induced epilepsy, DSIP acted as a potent anticonvulsant significantly decreasing both the incidence and duration of epileptic seizures

Maintenance phase: 25 mg once weekly for 48 weeks

Some people feel benefits quickly, while others notice steady improvements over several sessions

Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice
